Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1844 News Items found From Navy Veteran to MSK Cancer Researcher: Matthew Solowsky’s Story Thursday, November 11, 2021 Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center. Hillary Esposito’s Career Path: From the Military to MSK Thursday, November 11, 2021 Meet Hillary Esposito, who served in the US Military and is now an administrative assistant in Memorial Sloan Kettering Cancer Center's Department of Medicine. MSK Joins the Abyssinian Baptist Church to Answer COVID-19 Vaccine Questions Thursday, November 11, 2021 On November 3, 2021, a panel of MSK doctors joined The Abyssinian Baptist Church for an educational webinar about COVID-19 vaccination. Finding MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug Thursday, November 11, 2021 A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes. Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research Monday, November 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. A True Giant in Cancer Care: Memorial Sloan Kettering Cancer Center’s Richard J. O’Reilly, MD, Inducted into the 2021 Giants of Cancer Care® Friday, November 5, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Richard J. O’Reilly, MD, was named to the Ninth Annual Giants of Cancer Care®. In the Lab How Do Inherited Gene Mutations Cause Cancer? A New Database Will Help Researchers Find Out Friday, November 5, 2021 In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations. MSK Breast Cancer Expert Shares Tips for Women with Telemundo Audience Friday, November 5, 2021 MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month. Feature A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database Thursday, November 4, 2021 OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors. Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response Thursday, November 4, 2021 Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment